Article Details

Sumitovant Biopharma to buy Myovant for $27 per share - MarketScreener

Retrieved on: 2022-10-24 04:11:47

Tags for this article:

Click the tags to see associated articles and topics

Sumitovant Biopharma to buy Myovant for $27 per share - MarketScreener. View article details on hiswai:

Excerpt

Oct 23 (Reuters) - Sumitovant Biopharma Ltd, along with parent Sumitomo Pharma Co Ltd, has entered into a deal to purchase all shares of Myovant ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up